Hamamatsu Photonics K.k. · TSE:6965
Hamamatsu Photonics K.k — Q3 FY2025 Earnings Presentation
28 slides from Hamamatsu Photonics K.k's earnings presentation, August 2025
Slide 1: Fiscal Year ending September 30, 2025 Third Quarter Report
Fiscal Year ending September 30, 2025 Third Quarter Report Tokyo Stock Exchange : 6965 August, 2025 🄫 Hamamatsu Photonics K.K. and its affiliates. All Rights Reserved. 1
Slide 2: Point
Point ┃FY25 Q3 YTD Results （Unit : Billion yen） Sales 155.4 (YoY：+4.9) Operating profit 12.2 (YoY：-13.0) • Industrial (for Semiconductor instrument, etc.) • Increase in expenses due to M&A and Analytical remained steady, increasing from NKT Photonics (following is NKTP)：+8.6 previous period Fairchil
Slide 3: Agenda
Agenda 01 FY25 Q3 YTD Results 02 FY25 Forecasts 🄫 Hamamatsu Photonics K.K. and its affiliates. All Rights Reserved. 3
Slide 4: FY25 Q3 YTD Results
Agenda 01 FY25 Q3 YTD Results 02 FY25 Forecasts 🄫 Hamamatsu Photonics K.K. and its affiliates. All Rights Reserved. 4
Slide 5: Financial Results
Financial Results Sales increased due to M&A, but profits decreased （Unit : Billion yen） FY24 FY25 YoY Q3 YTD Q3 YTD Change % Sales 150.5 155.4 4.9 3.3 76.4 75.0 Gross profit -1.3 -1.8 (50.8 %) (48.3 %) 25.3 12.2 Operating profit -13.0 -51.4 (16.8%) (7.9 %) 20.4 9.6 Net profit -10.8 -52.9 (13.6%) (6
Slide 6: Sales by application
Sales by application ┃Pick up Medical-bio ・・・ Challenging business environment continues Industrial ・・・ Good situation continues, mainly in semiconductor industry Analytical ・・・ Good situation continues （Unit : Billion yen） FY24 FY25 YoY Q3 YTD Q3 YTD Change ％ Medical-bio 48.8 44.4 -4.4 -9.1 Industr
Slide 7: Quarterly Changes
Quarterly Changes Sales （Unit : Billion yen） Operating profit （Unit : Billion yen） 57.3 53.4 50.5 56.1 48.7 （Forecast） 6.8 6.4 46.5 5.2 5.7 （Actual） （Forecast） 4.2 1.5 （Actual） FY24Q3 FY24Q4 FY25Q1 FY25Q2 FY25Q3 FY25Q4 FY24Q3 FY24Q4 FY25Q1 FY25Q2 FY25Q3 FY25Q4 🄫 Hamamatsu Photonics K.K. and its…
Slide 8: Factors of Operating Profit Changes
Factors of Operating Profit Changes (Q3 YTD) FY24 – FY25 （Unit : Billion yen） Excluding impact of currency fluctuation 2.2 Operating profit 25.3 -13.0 Increase in gross profit due to -4.2 increase in sales Decrease due to lower gross profit margin 0.2 12.2 -11.3 Impact by currency Increase in SG&A f
Slide 9: Factors causing increases in SG&A and R&D expenses
Factors causing increases in SG&A and R&D expenses (Q3 YTD) FY24 – FY25 （Unit : Billion yen） Item Comment NKTP +2.2 R&D expenses +2.9 FI ＋0.6 NKTP +2.2 Personnel expenses +2.6 FI +0.3 Impact of M&A +9.7 Depreciation +0.3 NKTP +0.3 NKTP +1.3 Others +3.7 Goodwill amortization +2.3 R&D expenses +1.0 In
Slide 10: Sales by Region
Sales by Region （Unit : Billion yen） Asia Japan Asia Japan 44.4 34.2 47.0 34.3 (29.5 %) (22.7 %) (30.2 %) (22.1 %) FY24 Q3 YTD FY25 Q3 YTD 150.5 155.4 Europe North America Europe North America 31.9 39.6 36.9 36.7 (21.2 %) (26.3 %) (23.8 %) (23.7 %) FY24 Q3 YTD FY25 Q3 YTD Change % Japan 34.2 34.3 0.
Slide 11: Inventory status
Inventory status ┃Started efforts to shorten cash conversion cycle (CCC) • Increase in inventory assets is scheduled to be shipped in Q4 • Raw materials and supplies are being reduced based on company policy [Inventory trends] （Unit : Billion yen） [CCC] FY24Q4 FY25Q1 FY25Q2 FY25Q3 39.8 42.4 39.1 41.
Slide 12: FY25 Forecasts
Agenda 01 FY25 Q3 YTD Results 02 FY25 Forecasts 🄫 Hamamatsu Photonics K.K. and its affiliates. All Rights Reserved. 12
Slide 13: Forecasts
Forecasts Market has become uncertain due to impact of reciprocal tariffs imposed by US, and indirect effects are becoming apparent Medical-bio continued to face challenging business environment, and results fell short of expectations （Unit : Billion yen） YoY vs. plan FY24 FY25 FY25 (Actual) (Plan)
Slide 14: Factors of Operating Profit Changes
Factors of Operating Profit Changes (Full-Year) FY25 Plan-FY25 Forecasts （Unit : Billion yen） Excluding impact of currency fluctuation Operating profit -6.1 24.1 2.0 18.0 -4.5 1.8 Decrease in gross profit due to -5.4 Decrease in SG&A Impact by currency fluctuation decrease in sales Decrease due to e
Slide 15: Sales by application
Sales by application ┃Pick up Medical-bio ・・・ In addition to budget cuts for academic and biotechnology research by US government, business environment remains challenging due to uncertainties caused by reciprocal tariffs and other factors Industrial ・・・ Semiconductor instrument and non-destructive
Slide 16: Business status in Medical-bio
Business status in Medical-bio ▪Main factor Uncertain market conditions due to reciprocal tariffs imposed by US 🄫 Hamamatsu Photonics K.K. and its affiliates. All Rights Reserved. 16
Slide 17: Factors and Responses
Factors and Responses ▪CT・PET ▪Dental ▪Bio • Adoption of multiple suppliers for detectors • Commoditization of equipment (Low-priced • Decreased demand for equipment due to US (Unavoidable due to customer supply chain equipments from Chinese and South Korean government research funding cuts (flow po
Slide 18: Our strategy for CT detector business
Our strategy for CT detector business Focusing on supplying high value-added detectors for high-performance CT ・Expansion of CT market in China • Differentiation with direct conversion PC (photon counting) CT detectors Development agreement signed ・Increase in share of Chinese CT manufacturers in -
Slide 19: Sales trends by industry in US
Sales trends by industry in US Although major customers in US are strongly affected by US reciprocal tariffs and US government research funding cuts, sales are expected to increase from FY25 onwards (Unit：＄1 MM) 150 100 50 0 Radiographic testing Bio Semiconductor (CT、PET etc.) (Flow cytometer etc.)
Slide 20: Order trends
Order trends Strong order momentum continued following Q2 （FY23Q4を基準） Order trends （FY24Q1 Base） BB ratio 1.5 1.5 1 1 0.5 0.5 0 0 Order trends BB ratio 🄫 Hamamatsu Photonics K.K. and its affiliates. All Rights Reserved. 20
Slide 21: Quarterly Changes
Quarterly Changes Sales （Unit : Billion yen） Operating profit （Unit : Billion yen） 56.1 57.3 6.8 6.4 53.4 50.5 5.7 46.5 48.7 （Forecast） 5.2 （Actual） （Forecast） 4.2 1.5 （Actual） FY24Q3 FY24Q4 FY25Q1 FY25Q2 FY25Q3 FY25Q4 FY24Q3 FY24Q4 FY25Q1 FY25Q2 FY25Q3 FY25Q4 🄫 Hamamatsu Photonics K.K. and its…
Slide 22: Shareholder Return Policy
Shareholder Return Policy Basic policy is to pay stable dividends and consider share buybacks as appropriate 200 Buyback 81.1% 【Basic policy】 180 20.0 Dividend pay ratio Buyback 160 140 10.0 Billion yen Billion yen (Completed) 30％ target 120 100 37.5% 80 31.1% 29.7% 46.8% 27.0% 27.5% 60 【Minimum pol
Slide 23: Basic Policy for Management Improvement
Basic Policy for Management Improvement Identified issues • Strengthening competitiveness • Organizational structure that in Opto-semiconductor segment enables sustained corporate growth • Response to US reciprocal • Effective utilization of new tariffs factory (8-inch line) • Improving performance
Slide 24: 【TOPIC】Progress of Growth Strategy in Quantum
【TOPIC】Progress of Growth Strategy in Quantum 🄫 Hamamatsu Photonics K.K. and its affiliates. All Rights Reserved. 24
Slide 25: Current status: neutral atom quantum computer products
[Current status] For neutral atom quantum computer ORCA®-Quest 2 qCMOS® camera World's first low-noise camera capable of identifying photon numbers (qCMOS camera) now available Spatial light phase modulator (LCOS-SLM) is highly acclaimed LCOS-SLM 🄫 Hamamatsu Photonics K.K. and its affiliates. All…
Slide 26: NEDO Public Solicitation Quantum Computers Project
NEDO Public Solicitation “Acceleration of Development for Industrialization of Quantum Computers” Project Project Theme “Development of Optical Materials Technology for Industrialization of Quantum Computers” Selected as Sole Company Utilizing grant funds*, we will advance development of the followi
Slide 27: Notes
Notes ◼ This material is not intended to be a solicitation to buy or sell any securities of Hamamatsu Photonics K.K. ◼ The information contained in this material is based on data available as of making it. No guarantees, promises are made as to its accuracy or completeness. ◼ This material includes
Slide 28: 🄫 Hamamatsu Photonics K.K. and its affiliates. All Rights Reserved.
🄫 Hamamatsu Photonics K.K. and its affiliates. All Rights Reserved. 28
Hamamatsu Photonics K.K. — Q3 FY2025 Earnings Presentation on 6ix